塞来昔布通过Wnt信号通路对人结肠癌细胞的影响
2022-03-27杨春勇曲大鹏金若天
杨春勇 曲大鹏 金若天



[摘要] 目的 观察非甾体类抗炎药物(NSAIDs)塞来昔布(celecoxib)对结肠癌细胞Wnt信号通路的影响,探讨塞来昔布抑制结肠癌细胞生长的机制。方法 MTT法测定塞来昔布(0、20、40、60、80和100 μmol/L)对人结肠癌SW480细胞生长的影响;应用免疫细胞化学方法分析塞来昔布(0、20、40和80 μmol/L)处理48 h后细胞中β-catenin蛋白的分布表达情况;应用RT-PCR法分析塞来昔布(0、20、40和80 μmol/L)处理48 h后细胞中C-myc mRNA的表达水平。结果 MTT结果显示,塞来昔布能够抑制结肠癌细胞的生长增殖,且有剂量依赖性(P<0.05)和时间依赖性(P<0.05);免疫细胞化学法检测结果显示,细胞浆及细胞核内β-catenin蛋白随着塞来昔布浓度的增加表达显著下降(P<0.05); RT-PCR法检测结果显示,随着塞来昔布浓度的增加,C-myc mRNA表达下降,且呈剂量依赖性(P<0.05)。结论 塞来昔布可以通过调控Wnt/β-catenin信号通路抑制结肠癌细胞增殖。
[关键词] 塞来昔布;结肠癌;Wnt信号通路;β-catenin蛋白
[中图分类号] R735.3 [文献标识码] A [文章编号] 1673-9701(2022)05-0026-04
[Abstract] Objective To observe the effect of non-steroidal anti-inflammatory drugs (NSAIDs) celecoxib on Wnt/β-catenin signaling pathway in colon cancer SW480 cells and explore the molecular mechanism of celecoxib inhibiting the growth of colon tumors. Methods The effects of different concentrations of celecoxib (0, 20, 40, 60, 80, and 100 μmol/L) on the proliferation of SW480 cells were determined by MTT assay. Immunocytochemistry was used to analyze the distribution and expression of the β-catenin protein in the cells treated with different concentrations of celecoxib (0, 20, 40, and 80 μmol/L) for 48 hours. RT-PCR was used to analyze the expression levels of C-myc mRNA in the cells treated with different concentrations of celecoxib (0, 20, 40, and 80 μmol/L) for 48 hours. Results MTT assay showed that celecoxib could inhibit the proliferation of colon cancer cells in a concentration-dependent (P<0.05) and time-dependent (P<0.05) manner. Immunocytochemistry showed that the expression of the β-catenin protein in plasma and nucleus decreased significantly with the increase of celecoxib concentration (P<0.05). RT-PCR showed that the expression of C-myc mRNA decreased with the increase of celecoxib concentration in a dose-dependent manner (P<0.05). Conclusion Celecoxib can inhibit the proliferation of colon cancer cells by regulating the Wnt/β-catenin signaling pathway.
[Key words] Celecoxib; Colon cancer; Wnt signaling pathway; β-catenin protein
隨着人们物质生活水平的提高,导致生活方式的改变和生活环境的恶化,结肠癌的发病率逐年增加,成为世界上第三大最常见的癌症,也是癌症死亡的第二大主要原因。Globbocan的统计数据显示,2018年全球共有180万结直肠癌病例和88.1万人死亡,占所有癌症发病率的10.2%,占所有癌症相关死亡率的9.2%[1]。手术和化疗仍是最迫切的治疗方法,然而化疗的长期毒副作用和耐药性的发展构成了一个重大挑战。前期研究表明,非甾体类抗炎药物(NSAIDs)塞来昔布能够抑制结肠癌细胞生长及促进凋亡[2],但其具体机制尚不明确,而Wnt/β-catenin通路在人类多种肿瘤的发生发展过程中起着决定性的作用,尤其是结直肠癌。……
